Exploring Relative Mortality and Epoetin Alfa Dose Among Hemodialysis Patients

The observed mortality risk estimates associated with EPO dose in nonexperimental studies in dialysis patients may be highly sensitive to the analytic method used. This highlights the complexity of evaluating the association between EPO dose, Hb level, and mortality in these studies.